aztreonam has been researched along with Group A Strep Infection in 5 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Linezolid therapy was associated with improved clinical outcomes and significantly lower treatment costs than was vancomycin." | 2.72 | Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. ( Itani, KM; Liu, LZ; McKinnon, PS; Sorensen, SV, 2006) |
| "While group C beta hemolytic streptococcal infections are uncommon in humans, group C beta hemolytic streptococcal pneumonia is exceedingly rare." | 1.38 | Necrotizing pneumonia caused by group C streptococci in a young adult. ( Hurtado Rendon, IS; Pathak, V; Smina, M, 2012) |
| "In addition, combined treatments of bacterial infections should allow for a reduction in dosages of antibiotics while at the same time, achieving increased efficacy." | 1.28 | Potentiation by nonspecific immunostimulation of the efficacy of antibiotics in the treatment of experimental bacterial infections. ( Bizzini, B; Fattal-German, M, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pathak, V | 1 |
| Hurtado Rendon, IS | 1 |
| Smina, M | 1 |
| McKinnon, PS | 1 |
| Sorensen, SV | 1 |
| Liu, LZ | 1 |
| Itani, KM | 1 |
| Chandrasekar, PH | 1 |
| Smith, BR | 1 |
| LeFrock, JL | 1 |
| Carr, B | 1 |
| Bizzini, B | 1 |
| Fattal-German, M | 1 |
| León de Lope, M | 1 |
| Nogales Pérez, MC | 1 |
| Gálvez Acebal, J | 1 |
| Mañas Frías, R | 1 |
| Perea Pérez, EJ | 1 |
| Martínez-Luengas, F | 1 |
1 trial available for aztreonam and Group A Strep Infection
| Article | Year |
|---|---|
Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Clinical Trials as | 2006 |
4 other studies available for aztreonam and Group A Strep Infection
| Article | Year |
|---|---|
Necrotizing pneumonia caused by group C streptococci in a young adult.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Therapy, Combination; Humans; Lung Absces | 2012 |
Enterococcal superinfection and colonization with aztreonam therapy.
Topics: Anti-Bacterial Agents; Aztreonam; Humans; Streptococcal Infections; Streptococcus | 1984 |
Potentiation by nonspecific immunostimulation of the efficacy of antibiotics in the treatment of experimental bacterial infections.
Topics: Adjuvants, Immunologic; Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; | 1989 |
[Evaluation of azthreonam in the treatment of severe infections: study of 17 cases].
Topics: Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Colon; Drug Evaluation; Female; Humans | 1985 |